Publication date: Sep 15, 2025
There are limited data comparing viral shedding between influenza and SARS-CoV-2 in immunocompromised patients. We prospectively enrolled 70 SARS-CoV-2 and 16 influenza patients, with 48 SARS-CoV-2 patients matched to 16 influenza patients by propensity score. Weekly-collected respiratory samples were subjected to viral culture and antigen testing. In matched cohorts, the time to culture-confirmed viral clearance was shorter for influenza than SARS-CoV-2 (median, 4. 5 vs. 29 days; adjusted Hazard Ratio [aHR] 27. 5; P
| Concepts | Keywords |
|---|---|
| Immunocompromised | Immunoassay |
| Influenza | Influenza |
| Viral | SARS-CoV-2 |
| Weekly | viral shedding |
| virus culture |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | immunocompromised patients |
| disease | MESH | virus shedding |
| disease | MESH | influenza |
Original Article
(Visited 2 times, 1 visits today)